503a pharmacy bpc 157 Heal or Harm: Body Protective Compound-157 in the Gray Zone Big decisions could be coming

Big decisions could be coming for peptide compounding. Over the next few days, the FDA's Pharmacy Compounding Advisory Committee will discuss several peptides, including BPC 157, and whether they should be considered for 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! healthyaging #bpc157 #casapharmarx Casa Pharma RX Licensed Sterile 503A Compounding Pharmacy

SKU: 42528952038 · From equiscorp.hu